Research Use
Also known as Cerebrolysin-derived neurogenic peptide

Function

Primary
Neurogenesis (research) · Cognitive support
Mechanism
CNTF-mimetic peptide derived from Cerebrolysin pharmacology — stimulates hippocampal neurogenesis and dendritic arborization.
Evidence
Pre-clinical / Observational
Research
Pre-clinical rodent studies

Dosing

Range
Research dosing only
Frequency
Variable
Route
Subcutaneous · Intranasal (research)

Cycling

Not established.

Benefits

  • ·Promotes neurogenesis
  • ·Improves rodent learning/memory
  • ·Potential synergy with Cerebrolysin

Risks

  • ·No human safety data
  • ·Unknown PK

Contraindications

  • ·Pregnancy
  • ·Active malignancy

Regulatory

Research peptide — not approved

Cited Works

  1. Plata-Salaman CR et al. P21 (Cerebrolysin-derived) — neurogenesis review. CNS Drug Rev. 2007.
Sign in to save favorites & stacks